PEMIGATINIB

853 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking PEMIGATINIB:

# Side effect Count
0 OFF LABEL USE 155
1 DISEASE PROGRESSION 144
2 DEATH 86
3 FATIGUE 82
4 ALOPECIA 67
5 CHOLANGIOCARCINOMA 62
6 HYPERPHOSPHATAEMIA 54
7 DRUG INEFFECTIVE 48
8 DIARRHOEA 46
9 NAUSEA 43
See all common reactions for PEMIGATINIB

PEMIGATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND 1 0.5000
1 HIGH INTENSITY FOCUSED ULTRASOUND 1 0.3333
2 TUMOUR BIOPSY 1 0.2500
3 ADENOCARCINOMA OF SALIVARY GLAND 9 0.2308
4 STROKE-LIKE MIGRAINE ATTACKS AFTER RADIATION THERAPY 2 0.2000
5 RETROPERITONEAL NEOPLASM METASTATIC 5 0.1515
6 VASCULAR ACCESS SITE PRURITUS 1 0.0588
7 NAIL TOXICITY 17 0.0567
8 KIDNEY ABLATION 1 0.0455
9 TRICHOMEGALY 2 0.0455
See all enriched reactions for PEMIGATINIB